Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

J. Whang-Peng, D. E. Lees, W. H. Schuette, R. Smith, J. M. Bull, V. T. DeVita

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

Original languageEnglish
Pages (from-to)1103-1104
Number of pages2
JournalCancer Treatment Reports
Volume65
Issue number11-12
Publication statusPublished - Dec 1 1981
Externally publishedYes

Fingerprint

Osmotic Fragility
Fever
Erythrocytes
Drug Therapy
Adjuvant Chemotherapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Whang-Peng, J., Lees, D. E., Schuette, W. H., Smith, R., Bull, J. M., & DeVita, V. T. (1981). Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. Cancer Treatment Reports, 65(11-12), 1103-1104.

Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. / Whang-Peng, J.; Lees, D. E.; Schuette, W. H.; Smith, R.; Bull, J. M.; DeVita, V. T.

In: Cancer Treatment Reports, Vol. 65, No. 11-12, 01.12.1981, p. 1103-1104.

Research output: Contribution to journalArticle

Whang-Peng, J, Lees, DE, Schuette, WH, Smith, R, Bull, JM & DeVita, VT 1981, 'Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy', Cancer Treatment Reports, vol. 65, no. 11-12, pp. 1103-1104.
Whang-Peng J, Lees DE, Schuette WH, Smith R, Bull JM, DeVita VT. Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. Cancer Treatment Reports. 1981 Dec 1;65(11-12):1103-1104.
Whang-Peng, J. ; Lees, D. E. ; Schuette, W. H. ; Smith, R. ; Bull, J. M. ; DeVita, V. T. / Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy. In: Cancer Treatment Reports. 1981 ; Vol. 65, No. 11-12. pp. 1103-1104.
@article{8bede756c7e141688351403fff0679c1,
title = "Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy",
abstract = "The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.",
author = "J. Whang-Peng and Lees, {D. E.} and Schuette, {W. H.} and R. Smith and Bull, {J. M.} and DeVita, {V. T.}",
year = "1981",
month = "12",
day = "1",
language = "English",
volume = "65",
pages = "1103--1104",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "11-12",

}

TY - JOUR

T1 - Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy

AU - Whang-Peng, J.

AU - Lees, D. E.

AU - Schuette, W. H.

AU - Smith, R.

AU - Bull, J. M.

AU - DeVita, V. T.

PY - 1981/12/1

Y1 - 1981/12/1

N2 - The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

AB - The osmotic fragility of erythrocytes was studied in 24 patients receiving whole-body hyperthermia, with and without concomitant chemotherapy, for 2-4 hours as an adjuvant to chemotherapy for advanced metastatic disease. No alteration in osmotic fragility of erythrocytes was observed with whole-body hyperthermia.

UR - http://www.scopus.com/inward/record.url?scp=0019773176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019773176&partnerID=8YFLogxK

M3 - Article

C2 - 7296555

AN - SCOPUS:0019773176

VL - 65

SP - 1103

EP - 1104

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 11-12

ER -